The determination of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor (HER2), and Ki-67 were useful for defining subtypes of breast cancer which provided prognostic information and generally sufficient to guide adjuvant systemic treatment for patients (Curigliano et al., 2017). Here, ESR1 is linked to breast cancer.